Acetylsalicylic acid Completed Phase 3 Trials for Neurological Impairments / Stroke, Acute Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00276380A Study on the Use of TanakanĀ® for Recovery of Neurological Impairment Following Ischaemic Stroke